Therapy Areas: Autoimmune
US FDA Approves Pfizer's Biosimilar, Abrilada for Multiple Inflammatory Conditions
19 November 2019 - - The United States Food and Drug Administration has approved US-based pharmaceutical company Pfizer Inc.'s (NYSE: PFE) Abrilada (adalimumab-afzb), as a biosimilar to Humira&nb...
Magenta Therapeutics Presents First Immune Reset Results with Antibody-Drug Conjugate Across Multiple Autoimmune Diseases at ACR
13 November 2019 - - US-based biotechnology company Magenta Therapeutics (NASDAQ: MGTA) has presented new data showing successful immune reset with a single dose of its CD45-ADC in models of three aut...
Karo Phrama reports on termination of project by Pfizer regarding ROR-gamma
6 November 2019 - Karo Pharma AB (STO:KARO), a drug research and development company, announced on Tuesday that Pfizer has informed the company about its decision to terminate the specific development...
Samsung Biologics signs long term manufacturing contract with Ichnos Sciences
6 November 2019 - South Korea-based Samsung Biologics has signed a long term contract with United States-based Ichnos Sciences for manufacturing drug substance for ISB 830, an anti-OX40 monoclonal ant...
Can-Fite Initiates Compassionate Use Programme for Namodenoson in the Treatment of Liver Cancer, Enrolls and Treats Patients
5 November 2019 - - Israel-based biotechnology company Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI) has initiated its compassionate use programme for Namodenoson in the treatment of hepatocel...
Samsung Biologics partners with Ichnos Sciences for the manufacture of ISB 830 for atopic dermatitis
5 November 2019 - Biopharma CMO company Samsung Biologics disclosed on Monday the launch of a long-term agreement with Ichnos Sciences for manufacturing drug substance for ISB 830 as a potential treat...